FIRSTLY, Thank You @wednesdayschild for these insightful posts that you always provide.
Whether its good or bad news, you always do it in a very educational way. Admittedly, the material is often way too deep for some of us simpletons. You should not feel the need to apologise for reading the charts, the data, and everything else, and then reporting on your findings. It's brilliant and useful! We owe you! Thank you.
Now: I found a number of things quite interesting and I want to learn from you (as always);
a) You say price has outrun volume? What you say makes sense. Its led me to a question: Does the phenomenon apply to both an upward and a downward move? Did the share price crush have volume?
b) You say something that suggests to me that the chart needs a positive Announcement to back it (am I right)? If so, is that to suggest that TA trading alone (without FA) might not work well with the current chart set up? I know you do both TA, FA, and deep data analyses so what I am asking may not quite apply to you?
c) On the lack of news: could it be that that the market has lagged behind announcements and may perhaps be starting to correct that? I say this because I have counted more than a dozen price sensitive announcements in a space of just 6 months - yet the response to each was just a shoulder shrug! Or, would the lack of volume still mean we are in the same shoulder shrugging zone?
d) Is it that the market is simply ignoring the Announcements that have been made, while lying in wait for a different kind of Announcement (the one that has not come)? Again, I say this because to me, the quality has been Top notch for a biotech, especially with clinical trials data that has exceeded expectations (or did the market expect no less from Clarity)!
Let me repeat: I always appreciate your input - Positive or Negative views!
- Forums
- ASX - By Stock
- CU6 - ASX Charts
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.44%
!
$2.52

FIRSTLY, Thank You @wednesdayschild for these insightful posts...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M |
Open | High | Low | Value | Volume |
$2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | 2.500 |
1 | 6415 | 2.490 |
2 | 26415 | 2.480 |
2 | 7915 | 2.470 |
4 | 41204 | 2.450 |
Price($) | Vol. | No. |
---|---|---|
2.520 | 3500 | 1 |
2.530 | 1000 | 1 |
2.540 | 41066 | 4 |
2.550 | 30570 | 7 |
2.560 | 6415 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online